Take On Duchenne - North America

In this podcast episode we are discussing the topic of Nutrition and Duchenne with our guest speaker, Dr. Kindann Fawcett, Behavioral Health Scientist, Dietitian and Caregiver to her son with Duchenne Muscular Dystrophy. Our conversation with Dr. Kindann Fawcett explores;

·      the importance of healthy nutrition

·      the common nutritional deficits seen in patients

·      the fundamental nutritional elements for those with DMD

·      weight management

·      advocacy for people with Duchenne

Tune in to learn more about this topic.

US-EMF-0430 I November 2023

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2023 PTC Therapeutics. All rights reserved.

Hosted on Acast. See acast.com/privacy for more information.

Dr. Ellen Welch is the Chief Scientific Officer at PTC who has been researching and tackling Duchenne for more than 20 years. 

In this episode, Dr. Welch reflects on scientific advances in the last two decades and how it has contributed to progress in the Duchenne space.  

She also explains the growing appreciation for women who are carriers, whether manifesting or not, and why it is important to ensure continuous awareness and provision of care.   

Listen to the podcast for more.

US-DMD-0305 I July 2023

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2023 PTC Therapeutics. All rights reserved.

Hosted on Acast. See acast.com/privacy for more information.

A Mother and Carrier of Duchenne Muscular Dystrophy Shares Her Journey

Elizabeth’s journey with DMD began when her son was diagnosed at the age of five.

In this episode, Elizabeth reflects on the diagnosis of her son, her daughter’s and her own carrier diagnosis, family life, her coping mechanisms and management of the disease. Although her and her family’s lives have been impacted by DMD, her future outlook is positive and inspiring.

US-DMD-0304 I April 2023

PTC Therapeutics has provided financial compensation to Elizabeth Floyd for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2023 PTC Therapeutics, Inc. All Rights Reserved

Hosted on Acast. See acast.com/privacy for more information.

Cardiomyopathy Associated with Duchenne Muscular Dystrophy

In this episode with Dr. Linda Cripe, we learn more about cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD). We discuss care consideration and management strategies especially pertinent for manifesting DMD carriers and why screening and monitoring is so important. What more could be done to support carrier moms? Listen to the podcast to learn more.

US-DMD-0303 I February 2023

PTC Therapeutics has provided financial compensation to Dr. Cripe for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2023 PTC Therapeutics, Inc. All Rights Reserved

Hosted on Acast. See acast.com/privacy for more information.

Women & Duchenne

We are dedicating this episode to ‘Women & Duchenne’ in honor of World Duchenne Awareness Day which takes place every September 7. Tune in to hear from three incredible women: a clinical expert, a mother who is also a carrier and caregiver, and a scientist share their knowledge, perspectives and experiences. Each has a set of unique challenges to overcome in order to manage Duchenne Muscular Dystrophy (DMD). 

US-DMD-0294 I November 2022

PTC Therapeutics has provided financial compensation to Elizabeth Floyd and Dr. Cripe for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2022 PTC Therapeutics, Inc. All Rights Reserved

Hosted on Acast. See acast.com/privacy for more information.

This episode is dedicated to discussing Duchenne Muscular Dystrophy (DMD) continuum of disease with a focus on cardiopathology. Hear from our expert guest speaker, Dr. Villa about the importance of continuing standard of care guidelines to support cardiac health.

Chet Villa, MD is a Pediatric Cardiologist at Cincinnati Children’s Hospital Medical Center.

US-DMD-0277 I June 2022

PTC Therapeutics has provided financial compensation to Dr. Villa for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2022 PTC Therapeutics, Inc. All Rights Reserved

Hosted on Acast. See acast.com/privacy for more information.

This episode is dedicated to discussing Duchenne Muscular Dystrophy (DMD) continuum of disease and importance of continuation of care. Hear from our expert guest speaker, Dr. Mayer about the recommended DMD standard of care guidelines with regards to ongoing patient management and care. 

Oscar Henry Mayer, MD is a Professor of Clinical Pediatrics at The Perelman School of Medicine at the University of Pennsylvania, and an Attending Pulmonologist within the Division of Pulmonology at the Children’s Hospital of Philadelphia (CHOP).

US-DMD-0276 I April 2022

PTC Therapeutics has provided financial compensation to Dr. Mayer for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2022 PTC Therapeutics, Inc. All Rights Reserved

Hosted on Acast. See acast.com/privacy for more information.

As more and more boys and young men with DMD are transitioning into adulthood, there is an increasing emphasis on quality of life and psychosocial management. In this episode, we are joined by Sarah Stoney, licensed social worker from Children’s Hospital of Philadelphia for a discussion about considerations and strategies for social aspects of care. 

Sarah Stoney, MSW, LSW is an experiences and licensed social worker with a Master degree in Social Work acquired at the West Chester University. Sarah works at the Children’s Hospital of Philadelphia, Division of Neurology since 2014 and assists patients and their families navigate the complex medical system, advocates with families in their schools and throughout the community, and provides ongoing support to patients and families in the neuromuscular, leukodystrophy, and multiple sclerosis communities.

US-DMD-0266 / 01/19/2022

PTC Therapeutics has provided financial compensation to Sarah Stoney for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2022 PTC Therapeutics, Inc. All Rights Reserved.

Hosted on Acast. See acast.com/privacy for more information.

Dr. Elman is an adult neurologist at the University of Pennsylvania, in this episode she shares her experience and important considerations for a successful transition to adult care in Duchenne muscular dystrophy (DMD).  

In the last decade, improvements in DMD care and therapeutic strategies have contributed to better patient outcomes and prolonged patient survival. Today, more and more boys are transitioning into adulthood and planning for their futures, which brings new challenges and new opportunities. 

US-DMD-0258 I 12/09/2021

PTC Therapeutics has provided financial compensation to Dr. Elman for the time to conduct this interview.  

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2021 PTC Therapeutics, Inc. All Rights Reserved.

Hosted on Acast. See acast.com/privacy for more information.

In this episode, our guest speaker Dr. Diana Castro, Associate Professor of Pediatrics, Neurology and Neurotherapeutics at the University of Texas Southwestern shares her extensive clinical knowledge and discusses the clinical, diagnostic and medical landscape in DMD, as well as management approaches in the care of DMD.

Diana Castro, M.D., is a neurologist at Children’s Health℠ who specializes in pediatric neurology and neuromuscular medicine. She is also an assistant professor of pediatrics and neurology and neurotherapeutics at UT Southwestern Medical Center. She is the co-director of the Muscular Dystrophy Association Clinic in Dallas and is involved in multiple research protocols for spinal muscular atrophy (SMA) and Duchenne muscular dystrophy in the pediatric population.

PTC Therapeutics has provided financial compensation to Dr Castro for the time to conduct this interview.  

US-DMD-0252 I 09/28/21

Trademarks, registered or otherwise, are the property of their respective owner(s).

© 2021 PTC Therapeutics, Inc. All Rights Reserved.

Hosted on Acast. See acast.com/privacy for more information.